Study of bowel inflammation in adults with AML on intensive treatment
Part of Blood & lymphatic, Cancer, Digestive system clinical trials.
This study looks at how often a serious bowel problem (neutropenic enterocolitis) happens in adults with acute myeloid leukemia (AML) during intensive chemotherapy that lowers infection-fighting cells. The results may help doctors monitor and prevent complications during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have AML and be scheduled for intensive treatment (first induction, then additional intensive consolidation treatments) that is expected to cause low white blood cell counts and high infection risk
- Be able to give informed consent (agree to join the study)
- Have social security coverage
- Not be pregnant
- Not have acute promyelocytic leukemia, HIV, hepatitis B, or hepatitis C; and not be under court/administrative guardianship or deprived of freedom
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how childhood, teen, and young adult acute myeloid leukemia (AML) changes at the genetic level and how cells respond to multiple drugs. It may help doctors understand which treatments work best and how leukemia interacts with supportive cells in the bone marrow.
This study looks at how acute myeloid leukemia behaves over time in adults and may help doctors better predict outcomes. You might be eligible if you have AML and agree to take part in research.
This study looks at how inflammation (the body's response to injury or infection) affects treatment outcomes in people with acute myeloid leukemia (AML). If you have a new diagnosis or have stored samples from a past diagnosis, you may help researchers understand why some people respond better to therapy.
This study looks at infections in people with newly diagnosed acute myeloid leukemia (AML) starting from March 2025. It aims to understand how often infections happen and how they affect patients, so doctors can improve care.
This study compares different treatment intensities for adults with acute myeloid leukemia (AML) who are less able to handle strong chemotherapy. It aims to find the best approach for people with health issues like heart or lung problems that make standard chemo riskier.
This study looks at how blood counts and clotting change in adults newly diagnosed with acute myeloid leukemia (AML) who receive a strong type of chemotherapy. It aims to better understand how to manage these patients during treatment.
Hear when a new Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.